Clinical trials of a matrix metalloproteinase inhibitor in human periodontal disease. SDD Clinical Research Team.
about
Drugs in development: bisphosphonates and metalloproteinase inhibitorsPeriodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review.Anti-inflammatory Actions of Adjunctive Tetracyclines and Other Agents in Periodontitis and Associated Comorbidities.Matrix metalloproteinase biology applied to vitreoretinal disorders.Rationale for use of antibiotics in periodontics.Metalloproteinases: their role in arthritis and potential as therapeutic targets.Dieckol from Ecklonia cava Regulates Invasion of Human Fibrosarcoma Cells and Modulates MMP-2 and MMP-9 Expression via NF-κB Pathway.Efficacy of sub-antimicrobial dose doxycycline in post-menopausal women: clinical outcomesPerioceutics: Matrix metalloproteinase inhibitors as an adjunctive therapy for inflammatory periodontal diseaseNon-antibacterial tetracycline formulations: clinical applications in dentistry and medicineMinocycline for short-term neuroprotectionRepurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocyclineMatrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation.Novel host response therapeutic approaches to treat periodontal diseases.Diagnosis and anti-infective therapy of periodontitis.Host-response therapeutics for periodontal diseasesLong-lasting tissue inflammatory processes trigger autoimmune responses to extracellular matrix molecules.Periodontitis and cardiovascular diseases.Long-term efficacy of subantimicrobial-dose doxycycline as an adjunctive treatment to scaling and root planing: a systematic review and meta-analysis.Matrix metalloproteinases and periodontal diseases.Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers.Anti-inflammatory properties of low and high doxycycline doses: an in vitro study.The effect of adjunctive low-dose doxycycline and licorice therapy on gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis.Repurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocycline.The effect of chemical inhibition of matrix metalloproteinases on the size of experimentally induced apical periodontitis.Characteristics of collagenase-2 from gingival crevicular fluid and peri-implant sulcular fluid in periodontitis and peri-implantitis patients: pilot study.
P2860
Q24795847-F7138F3E-5969-43D6-AD75-51ED64CD9CD1Q31048527-BB2A7BE4-4FB7-4FCB-87EF-B9C1D15BDA59Q33815397-B4364D23-A1AD-4ED7-B25D-09A9D57D07E4Q33933063-FEDC3070-52FA-4768-9191-06740549569FQ34989249-6A5D72FD-678A-4CDF-B27F-82798BC6A64FQ35056019-C36F2356-3867-4228-B029-7BCFA145FC20Q35151646-B8E07C7A-43E2-4633-ABB2-8F7073C45C20Q36303676-F5AE5079-6DF2-4F8D-B4BF-45C7C8185216Q36307495-732BAF19-8CF9-45B5-99DA-84BDC99CDF80Q36317523-2BEA2695-207C-4459-87A5-21E073385C63Q36428406-5E1F5AA9-F862-4C96-BD74-61EFB4DA05B7Q36514428-44E3CED9-A395-4CF1-9D06-C34F6F44741EQ36580334-82CC1AD7-D97D-4DB4-A03B-B4DDAE1C2005Q36703987-BD2D3221-8829-447D-A192-1EDEDD4A0070Q36901965-254D9951-C7EC-421B-AAF1-8CE40BF13E4CQ36973411-D132F270-90F6-4956-8569-B742F0EFB439Q37147938-5E3BAD95-E701-4980-85B6-041AFDE0E7D9Q37777159-8FD159F5-238B-46DC-A432-087FA9AB0B4AQ37854591-7D5B89E7-D0BA-4740-9EB5-4CA7E3081DA4Q38121188-666857FD-2713-4F6F-97B9-63FAF366FDBFQ38870841-83CC7E68-47A9-48B4-8570-44FC418EE015Q38874520-B1E0C95C-9FB9-4E71-8406-2D0B6879CF61Q41763116-4DFD9F87-F81A-4946-9DB7-C2AA2D106EC5Q41847547-98C2C2F7-49C1-41E9-9C81-B7D29C7E4AD1Q47301276-ADE5F2BF-223C-453B-AE6B-8FB83B944998Q47584457-7C64F8A7-EBB4-418C-9CE8-0E61376E750E
P2860
Clinical trials of a matrix metalloproteinase inhibitor in human periodontal disease. SDD Clinical Research Team.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Clinical trials of a matrix me ...... e. SDD Clinical Research Team.
@en
Clinical trials of a matrix me ...... e. SDD Clinical Research Team.
@nl
type
label
Clinical trials of a matrix me ...... e. SDD Clinical Research Team.
@en
Clinical trials of a matrix me ...... e. SDD Clinical Research Team.
@nl
prefLabel
Clinical trials of a matrix me ...... e. SDD Clinical Research Team.
@en
Clinical trials of a matrix me ...... e. SDD Clinical Research Team.
@nl
P1476
Clinical trials of a matrix me ...... e. SDD Clinical Research Team.
@en
P2093
P304
P356
10.1111/J.1749-6632.1999.TB07693.X
P577
1999-06-01T00:00:00Z